You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

combination

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FDC, Diabetes, Type 2 Trial in Cheongju-si (DWC202213, DWJ1563, DWP16001)

Recruiting
  • FDC
  • Diabetes Mellitus, Type 2
  • Cheongju-si, Seowon-gu, Korea, Republic of
    Chungbuk National University Hospital
Feb 10, 2023

Recurrent Ovarian Cancer Trial in Shanghai (Fuzuloparib Combination with Bevacizumab)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • Fuzuloparib Combination with Bevacizumab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Cente
Apr 14, 2023

Advanced Solid Tumor Trial (CVL218)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 9, 2023

Primary Condition: Advanced Tumors Trial in Guangzhou (JS009 as a monotherapy and JS009 as a Triple Combination Therapy in

Not yet recruiting
  • Primary Condition: Advanced Tumors
  • JS009 as a monotherapy and JS009 as a Triple Combination Therapy in Combination with Toripalimab and JS006
  • Blacktown, New South Wales, Australia
  • +3 more
Feb 1, 2023

Switch From Etravirine to Doravirine asPart of Antiretroviral

Not yet recruiting
  • HIV Infections
    • (no location specified)
    Nov 24, 2023

    Hepatocellular Carcinoma Trial in Nanjing, Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Nanjing, Jiangsu, China
    • +1 more
    Jul 28, 2023

    Androgenetic Alopecia Trial in Jakarta (Minoxidil 5% Topical Solution, microneedling)

    Recruiting
    • Androgenetic Alopecia
    • Minoxidil 5% Topical Solution
    • microneedling
    • Jakarta, DKI Jakarta, Indonesia
      Cipto Mangungkusumo Hospital
    Aug 3, 2023

    Melanoma Trial (Fluzoparib Camrelizumab Temozolomide)

    Not yet recruiting
    • Melanoma
    • Fluzoparib Camrelizumab Temozolomide
    • (no location specified)
    Aug 9, 2023

    TNFi as Monotherapy or Combination Therapy With MTX and Compare

    Completed
    • Rheumatoid Arthritis
    • patterns of use of combination therapy and monotherapy
    • New York, New York
      Pfizer
    Oct 7, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

    Available
    • Paroxysmal Nocturnal Hemoglobinuria
    • (no location specified)
    Aug 31, 2023

    Body Composition, Lean Body Mass, Muscle Strength Trial in Odense (Effect of collagen peptides, in combination with resistance

    Recruiting
    • Body Composition
    • +3 more
    • Effect of collagen peptides, in combination with resistance training, on body composition and muscle strength compared to placebo in untrained men
    • Placebo Control intervention: Effect of resistance training in combination with placebo (silicon dioxide), on body composition and muscle strength in untrained men
    • Odense, Denmark
      The Department of Sports Science and Clinical Biomechanics at Un
    Sep 27, 2023

    Metastatic Breast Cancer Trial (Inavolisib, Phesgo, Placebo)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Jun 7, 2023

    Advanced Solid Tumors Trial (AMG 355, Pembrolizumab)

    Not yet recruiting
    • Advanced Solid Tumors
    • (no location specified)
    Nov 9, 2023

    Advanced Solid Tumors Trial (INCB099280, adagrasib)

    Not yet recruiting
    • Advanced Solid Tumors
    • (no location specified)
    Sep 8, 2023

    Pancreatic Cancer Trial in Aurora (TTI-101)

    Not yet recruiting
    • Pancreatic Cancer
    • Aurora, Colorado
      University of Colorado
    Nov 30, 2023

    Acute Kidney Injury Trial in Kuala Lumpur (Aminophylline, Frusemide)

    Recruiting
    • Acute Kidney Injury
    • Kuala Lumpur, Malaysia
      University of Malaya
    Jul 9, 2023

    Orthodontic Pain Trial in Salt Lake City (Acetaminophen/Naproxen Sodium Fixed Combination)

    Not yet recruiting
    • Orthodontic Pain
    • Acetaminophen/Naproxen Sodium Fixed Combination
    • Salt Lake City, Utah
      JBR Clinical Research LLP
    Apr 25, 2023

    Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

    Not yet recruiting
    • Carcinoma
    • +7 more
    • (no location specified)
    Nov 12, 2023

    Advanced Solid Tumor Trial (FB849, FB849 Monotherapy, FB849 in Combination with Pembrolizumab (Type A cancer))

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Feb 27, 2023

    Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)

    Not yet recruiting
    • Advanced Renal Cell Carcinoma
    • (no location specified)
    Jun 23, 2023

    AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

    Recruiting
    • AML
    • MDS
    • Tuebingen, Baden-Wuerttemberg, Germany
      University Hospital
    Nov 30, 2023

    Stomach Tumor Trial (Trastuzumab deruxtecan, Afatinib)

    Not yet recruiting
    • Stomach Neoplasm
    • (no location specified)
    Oct 16, 2023

    Recurrent Uti Trial in Chicago (Saccharomyces Boulardii 250 MG [Florastor])

    Recruiting
    • Recurrent Uti
    • Saccharomyces Boulardii 250 MG [Florastor]
    • Chicago, Illinois
      Lurie Children's Hospital
    Nov 21, 2023

    Metastatic Breast Cancer Trial (Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Lasofoxifene in combination with abemaciclib
    • Fulvestrant in combination with abemaciclib
    • (no location specified)
    Jan 25, 2023

    Gastrointestinal Cancer Trial (Capecitabine, Sacituzumab govetican)

    Not yet recruiting
    • Gastrointestinal Cancer
    • (no location specified)
    Oct 2, 2023